Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors

Richard E. Mewshaw, Lisa S. Silverman, Rose M. Mathew, Carl Kaiser, Ronald G. Sherrill, Menyan Cheng, Carol W Tiffany, E. William Karbon, Michael A. Bailey, Susan A. Borosky, John W. Ferkany, Mary E. Abreu

Research output: Contribution to journalArticle

Abstract

A series of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles and 6,7,8,9,10,11-hexahydro-7,-11-imino-5H-cyclooct[b]indoles was prepared. Structural modifications of the lead compound, 11-[4-(4-fluorobenzoyl)propyl]-5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b] indole (5, Ki = 0.82 nM vs [3H]ketanserin) enabled the identification of the functionality necessary for high affinity at serotonin 5-HT2 and dopamine D2 receptors in ligand binding studies. The indole ring, as well as the benzoyl or isosteric benzisoxazole moiety, were essential for high affinity. Variations of the length of the side chains resulted in ligands having either selective affinity for the 5-HT2 receptor or a combination of 5-HT2 and D2 affinity. In vivo binding studies were performed on selected members in this series. The most potent member, 2-fluoro-11-[4-(4-fluorobenzoyl)butyl]-5,6,7,8,9,-10-hexahydro-7,10- iminocyclohept[b]indole (36) had an ED50 of 2 and D2 receptors following oral administration.

Original languageEnglish (US)
Pages (from-to)1488-1495
Number of pages8
JournalJournal of Medicinal Chemistry
Volume36
Issue number10
StatePublished - 1993
Externally publishedYes

Fingerprint

Carbolines
Indoles
Derivatives
Ligands
Lead compounds
Ketanserin
Dopamine D2 Receptors
Oral Administration
Serotonin
indole

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Mewshaw, R. E., Silverman, L. S., Mathew, R. M., Kaiser, C., Sherrill, R. G., Cheng, M., ... Abreu, M. E. (1993). Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors. Journal of Medicinal Chemistry, 36(10), 1488-1495.

Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors. / Mewshaw, Richard E.; Silverman, Lisa S.; Mathew, Rose M.; Kaiser, Carl; Sherrill, Ronald G.; Cheng, Menyan; Tiffany, Carol W; Karbon, E. William; Bailey, Michael A.; Borosky, Susan A.; Ferkany, John W.; Abreu, Mary E.

In: Journal of Medicinal Chemistry, Vol. 36, No. 10, 1993, p. 1488-1495.

Research output: Contribution to journalArticle

Mewshaw, RE, Silverman, LS, Mathew, RM, Kaiser, C, Sherrill, RG, Cheng, M, Tiffany, CW, Karbon, EW, Bailey, MA, Borosky, SA, Ferkany, JW & Abreu, ME 1993, 'Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors', Journal of Medicinal Chemistry, vol. 36, no. 10, pp. 1488-1495.
Mewshaw RE, Silverman LS, Mathew RM, Kaiser C, Sherrill RG, Cheng M et al. Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors. Journal of Medicinal Chemistry. 1993;36(10):1488-1495.
Mewshaw, Richard E. ; Silverman, Lisa S. ; Mathew, Rose M. ; Kaiser, Carl ; Sherrill, Ronald G. ; Cheng, Menyan ; Tiffany, Carol W ; Karbon, E. William ; Bailey, Michael A. ; Borosky, Susan A. ; Ferkany, John W. ; Abreu, Mary E. / Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors. In: Journal of Medicinal Chemistry. 1993 ; Vol. 36, No. 10. pp. 1488-1495.
@article{9cdbe4cd8075407da9ab5fd9cde51960,
title = "Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors",
abstract = "A series of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles and 6,7,8,9,10,11-hexahydro-7,-11-imino-5H-cyclooct[b]indoles was prepared. Structural modifications of the lead compound, 11-[4-(4-fluorobenzoyl)propyl]-5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b] indole (5, Ki = 0.82 nM vs [3H]ketanserin) enabled the identification of the functionality necessary for high affinity at serotonin 5-HT2 and dopamine D2 receptors in ligand binding studies. The indole ring, as well as the benzoyl or isosteric benzisoxazole moiety, were essential for high affinity. Variations of the length of the side chains resulted in ligands having either selective affinity for the 5-HT2 receptor or a combination of 5-HT2 and D2 affinity. In vivo binding studies were performed on selected members in this series. The most potent member, 2-fluoro-11-[4-(4-fluorobenzoyl)butyl]-5,6,7,8,9,-10-hexahydro-7,10- iminocyclohept[b]indole (36) had an ED50 of 2 and D2 receptors following oral administration.",
author = "Mewshaw, {Richard E.} and Silverman, {Lisa S.} and Mathew, {Rose M.} and Carl Kaiser and Sherrill, {Ronald G.} and Menyan Cheng and Tiffany, {Carol W} and Karbon, {E. William} and Bailey, {Michael A.} and Borosky, {Susan A.} and Ferkany, {John W.} and Abreu, {Mary E.}",
year = "1993",
language = "English (US)",
volume = "36",
pages = "1488--1495",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Bridged γ-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors

AU - Mewshaw, Richard E.

AU - Silverman, Lisa S.

AU - Mathew, Rose M.

AU - Kaiser, Carl

AU - Sherrill, Ronald G.

AU - Cheng, Menyan

AU - Tiffany, Carol W

AU - Karbon, E. William

AU - Bailey, Michael A.

AU - Borosky, Susan A.

AU - Ferkany, John W.

AU - Abreu, Mary E.

PY - 1993

Y1 - 1993

N2 - A series of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles and 6,7,8,9,10,11-hexahydro-7,-11-imino-5H-cyclooct[b]indoles was prepared. Structural modifications of the lead compound, 11-[4-(4-fluorobenzoyl)propyl]-5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b] indole (5, Ki = 0.82 nM vs [3H]ketanserin) enabled the identification of the functionality necessary for high affinity at serotonin 5-HT2 and dopamine D2 receptors in ligand binding studies. The indole ring, as well as the benzoyl or isosteric benzisoxazole moiety, were essential for high affinity. Variations of the length of the side chains resulted in ligands having either selective affinity for the 5-HT2 receptor or a combination of 5-HT2 and D2 affinity. In vivo binding studies were performed on selected members in this series. The most potent member, 2-fluoro-11-[4-(4-fluorobenzoyl)butyl]-5,6,7,8,9,-10-hexahydro-7,10- iminocyclohept[b]indole (36) had an ED50 of 2 and D2 receptors following oral administration.

AB - A series of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles and 6,7,8,9,10,11-hexahydro-7,-11-imino-5H-cyclooct[b]indoles was prepared. Structural modifications of the lead compound, 11-[4-(4-fluorobenzoyl)propyl]-5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b] indole (5, Ki = 0.82 nM vs [3H]ketanserin) enabled the identification of the functionality necessary for high affinity at serotonin 5-HT2 and dopamine D2 receptors in ligand binding studies. The indole ring, as well as the benzoyl or isosteric benzisoxazole moiety, were essential for high affinity. Variations of the length of the side chains resulted in ligands having either selective affinity for the 5-HT2 receptor or a combination of 5-HT2 and D2 affinity. In vivo binding studies were performed on selected members in this series. The most potent member, 2-fluoro-11-[4-(4-fluorobenzoyl)butyl]-5,6,7,8,9,-10-hexahydro-7,10- iminocyclohept[b]indole (36) had an ED50 of 2 and D2 receptors following oral administration.

UR - http://www.scopus.com/inward/record.url?scp=0027211949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027211949&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 1488

EP - 1495

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 10

ER -